Shielding Your Beauty Empire: Advanced Strategies for IP Protections and Anti-Counterfeiting
September 26, 2024
On Thursday, September 26, Foley partner Kiri Lee Sharon will speak on the panel “Shielding Your Beauty Empire: Advanced Strategies for IP Protections and Anti-Counterfeiting” at the American Conference Institute’s (ACI) Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products West Coast Edition in Santa Monica, California.
The panel will cover the importance of implementing a proactive online brand protection strategy for companies facing threats of counterfeiting, and practices for continuous vigilance in detecting and removing brand infringements and counterfeit goods. The panel will focus on key topics including:
- Examining comprehensive IP tactics, from trademarks and copyrights to trade secrets and customs registration for safeguarding against counterfeit products
- Considering the use of high-tech features than can distinguish real products from fake, such as microscopic dots, QR codes or holographic stickers on packaging
- Reviewing the role of AI and how this is impacting IP rights
- Establishing a worldwide, reliable, and secure supply chain with suppliers and distributors, supported by robust contracts and non-disclosure agreements
- Analyzing the role of enforcement agencies in preventing counterfeiting and infringing activities
Click here to visit the conference website with more details.
People
Related Insights
December 4, 2025
Manufacturing Industry Advisor
Foley Automotive Update
Analysis by Julie Dautermann, Competitive Intelligence Analyst Foley is here to help you through all aspects of rethinking your long-term…
December 4, 2025
Foley Viewpoints
Foley Event Key Takeaways- Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shift
Foley & Lardner, Protiviti and SS&C Intralinks recently hosted an event in Foley’s Silicon Valley office at Palo Alto Center. Moderated by Foley partner Louis Lehot, the session titled "Ready for Anything: Preparing for IPOs, SPACs, and Unexpected Capital Market Shifts," brought together industry leaders: JD Fay (ex-CFO, Matterport, de-SPAC’d and then sold to CoStar Group), Dan Angus (Managing Director, Nasdaq), and Andrea Vardaro Thomas (Managing Director, Protiviti). Their combined experience provided a roadmap for companies facing the volatile and rapidly shifting capital markets of 2026.
December 4, 2025
Foley Viewpoints
FDA Guidance on Biosimilars Highlights Glycosylation Profiling and Increases the Strategic Value of Patents Covering Antibodies Defined by Glycosylation
FDA’s September 2025 guidance requires detailed characterization of posttranslational modifications (PTMs), particularly glycosylation,…